V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330005941 | 330002813 | 1.77 | 88.7 | Palliative (P) | 2018-03-22 | 2018-03-22 | Cetuximab +Cisplatin + FU (Cycle 1) | 2 | N | 330008362 | VIDE |
| 330005942 | 330002814 | 1.81 | 95.3 | null | 2019-01-22 | 2019-01-22 | DOXORUBICIN + IFOSFAMIDE | 02 | N | 330008554 | AML17 TRIAL |
| 330005943 | 330002815 | null | 0 | Palliative (P) | 2018-01-13 | 2018-01-14 | Cyclophosphamide + Vincristine | N | N | 330008806 | DOCETAXEL + GEMCITABINE |
| 330005944 | 330002815 | null | 55.6 | Not known (9) | 2015-01-02 | 2015-01-20 | RUXOLITINIB | N | null | 330008806 | TEMOZOLOMIDE |
| 330005945 | 330010100 | null | 135.8 | Curative (C) | null | 2018-11-09 | CNS LGG 2004 03 vinc weekly+ carbo | null | null | 330009383 | VIDE |
| 330005946 | 330010100 | 0 | null | Palliative (P) | 2014-05-27 | 2014-05-27 | Midostaurin | 02 | N | 330009383 | FLUOROURACIL + MITOMYCIN |
| 330005947 | 330010100 | 1.68 | 69.9 | Disease modification (D) | 2016-03-26 | 2016-03-26 | Cetuximab +Cisplatin + FU (Cycle 1) | 2 | N | 330009383 | TCF |
| 330005948 | 330010100 | 1.67 | 67.5 | Palliative (P) | 2014-03-28 | 2014-04-12 | VIDE | 1 | null | 330009383 | PEMBROLIZUMAB |
| 330005949 | 330002816 | 1.7 | 72 | Palliative (P) | null | 2019-01-13 | CARBOPLATIN + RT | N | N | 330009516 | IPILIMUMAB |
| 330005950 | 330002817 | null | 24.4 | Disease modification (D) | 2016-12-15 | 2016-12-16 | Docetaxel+Gemcitabine (no prior RT) | Y | N | 330009558 | VIDE |
| 330005951 | 330002818 | null | 65 | Curative (C) | 2018-05-12 | 2018-05-20 | CYCLO + RITUXIMAB + VINCRISTINE | N | N | 330009579 | PILOT TRIAL |
| 330005952 | 330002819 | 0 | 87 | Palliative (P) | 2013-12-21 | 2013-12-29 | BEP 3 day | 02 | N | 330009587 | CARBOPLATIN + CETUXIMAB + FU |
| 330005953 | 330002820 | 1.7 | 80 | Palliative (P) | 2017-03-12 | 2017-03-12 | Cladribine (subcut) 5 days | N | N | 330009636 | CHLORAMBUCIL |
| 330005954 | 330002820 | 1.79 | null | null | null | 2013-07-11 | Paclitaxel 7 day | null | null | 330009636 | CARBOPLATIN + VINCRISTINE |
| 330005955 | 330002821 | 0 | null | Curative (C) | 2018-11-19 | 2018-11-19 | Azacitidine | N | N | 330009736 | BEP |
| 330005956 | 330002822 | 1.66 | 79.05 | Palliative (P) | 2018-08-09 | 2018-08-09 | Pazopanib | N | N | 330009744 | GEMCITABINE |
| 330005957 | 330002823 | 1.69 | 11.9 | Adjuvant (A) | 2017-10-03 | 2017-10-16 | Chlorambucil | N | N | 330009760 | FLAG + IDARUBICIN |
| 330005958 | 330002823 | 1.48 | 50 | Neo-adjuvant (N) | 2018-05-15 | 2018-05-15 | CHOP - 21 days | 02 | N | 330009760 | EMA |
| 330005959 | 330002824 | null | null | Curative (C) | null | 2014-04-10 | Doxorubicin + Olaratumab | null | null | 330009845 | CHLORAMBUCIL + RITUXIMAB |
| 330005960 | 330002825 | 1.75 | 111 | Adjuvant (A) | 2016-10-26 | 2016-10-28 | Irinotecan + Temozolomide | N | N | 330009848 | CISPLATIN + VINORELBINE |
| 330005961 | 330002826 | null | 80.5 | Palliative (P) | 2015-11-07 | 2015-11-08 | RUXOLITINIB | 02 | null | 330009852 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 330005964 | 330002827 | 1.85 | 70 | null | 2017-02-19 | 2017-03-23 | Cytarabine Low Dose | N | Y | 330010001 | FLAG + IDARUBICIN |
| 330005965 | 330002828 | 1.58 | 63 | Palliative (P) | 2013-06-23 | 2013-06-29 | EVEROLIMUS | 2 | N | 330010071 | CVD |
| 330005966 | 330002829 | 1.79 | null | Curative (C) | 2017-08-13 | 2017-08-30 | Vemurafenib | N | N | 330010099 | METHOTREXATE INTRATHECAL |
| 330005967 | 330002830 | 1.6 | 72.1 | Palliative (P) | 2015-10-08 | 2015-10-08 | Ipilimumab | 2 | null | 330010106 | DOXORUBICIN + OLARATUMAB |
| 330005968 | 330002831 | null | 96.7 | Curative (C) | null | 2017-06-21 | Docetaxel + Gemcitabine with GCSF | null | null | 330010132 | AZACITIDINE |
| 330005969 | 330002832 | 1.58 | 12.8 | Curative (C) | 2014-12-09 | 2014-12-18 | ECX | N | N | 330010151 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 330005970 | 330002833 | 2.05 | 95.3 | Curative (C) | 2013-08-10 | 2013-12-08 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | N | N | 330010223 | CLADRIBINE |
| 330005971 | 330002834 | 1.72 | 76.3 | Disease modification (D) | 2013-08-07 | 2013-08-07 | PACLITAXEL | Y | N | 330010239 | VEPEMB |
| 330005972 | 330002834 | 1.71 | 43 | Palliative (P) | 2016-01-21 | 2016-01-24 | Carboplatin + Doxorubicin | 2 | N | 330010239 | CAPECITABINE + LAPATINIB |
| 330005973 | 330002835 | null | null | Disease modification (D) | 2016-10-14 | 2016-10-14 | CARBOPLATIN + RT | null | null | 330010325 | UKALL 2011 |
| 330005974 | 330002836 | 1.57 | 7.2 | Curative (C) | 2017-11-24 | 2017-11-28 | Methotrexate + Folinic acid | 02 | N | 330010407 | AZACITIDINE |
| 330005975 | 330002836 | null | 0 | Palliative (P) | null | 2016-06-21 | FLUOROURACIL + MITOMYCIN | 1 | null | 330010407 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB |
| 330005976 | 330010102 | null | 63 | null | 2015-05-22 | 2015-06-19 | DOCETAXEL + GEMCITABINE | N | null | 330010555 | ADE |
| 330005977 | 330010102 | null | 58.4 | Palliative (P) | null | 2016-02-29 | Cisplatin + Fluorouracil + RT 5day | N | N | 330010555 | HYDROXYCARBAMIDE |
| 330005978 | 330010102 | 1.77 | 84.9 | Curative (C) | null | 2015-01-02 | RUXOLITINIB | null | null | 330010555 | CHOP R |
| 330005979 | 330010102 | null | 45.7 | Palliative (P) | 2017-10-23 | 2017-10-23 | CARBOPLATIN + VINCRISTINE | 02 | N | 330010555 | IFOSFAMIDE |
| 330005980 | 330002837 | null | 72.3 | Adjuvant (A) | 2018-03-22 | 2018-03-22 | Capecitabine + Streptozocin | null | N | 330010913 | CARBOPLATIN + RT |
| 330005981 | 330002838 | 1.58 | 20.9 | Curative (C) | 2014-12-08 | 2014-12-08 | CARBOPLATIN + Cetuximab + FLUOROURACIL | Y | N | 330011047 | CAV |
| 330005982 | 330002838 | 1.78 | 72.1 | Disease modification (D) | 2017-12-03 | 2017-12-03 | FLAG + Idarubicin | N | N | 330011047 | CYTARABINE |
| 330005983 | 330002838 | 1.79 | 61.4 | Disease modification (D) | 2018-01-15 | 2018-01-23 | PEI | N | N | 330011047 | PACLITAXEL |
| 330005984 | 330002838 | 1.64 | 67 | Not known (9) | 2014-01-13 | 2014-02-15 | IPILIMUMAB + NIVOLUMAB | N | N | 330011047 | SUNITINIB |
| 330005985 | 330002838 | 0 | null | Curative (C) | 2017-10-27 | 2017-10-31 | Methotrexate + Folinic acid | 2 | N | 330011047 | ETOPOSIDE + IFOSFAMIDE |
| 330005986 | 330002838 | 1.8 | 66.8 | Curative (C) | 2017-07-08 | 2017-07-08 | AML16 DA 3+10 | 02 | N | 330011047 | CYCLOPHOSHAMIDE + RITUXIMAB |
| 330005987 | 330002838 | 1.55 | 51.5 | Curative (C) | 2016-04-15 | 2016-05-18 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | y | 330011047 | CYCLOPHOSPHAMIDE |
| 330005988 | 330002838 | null | null | Neo-adjuvant (N) | 2016-09-11 | 2016-09-15 | Cisplatin + Vinorelbine (IV) | N | null | 330011047 | AML17 TRIAL |
| 330005989 | 330002838 | 1.69 | 58.9 | null | 2017-07-02 | 2017-07-08 | Paclitaxel 7 day | 99 | N | 330011047 | CISPLATIN + VINORELBINE |
| 330005990 | 330002839 | 1.72 | 83.8 | Curative (C) | null | 2014-07-10 | AML17 TRIAL | null | null | 330011954 | VINBLASTINE |
| 330005991 | 330007537 | 1.65 | 85.7 | Palliative (P) | 2018-07-09 | 2018-07-30 | FLUOROURACIL + MITOMYCIN | 2 | N | 330011961 | CHLORAMBUCIL |
| 330005992 | 330007537 | 1.64 | 81.6 | Curative (C) | 2016-12-31 | 2016-12-31 | Cytarabine Intrathecal (any age) | N | N | 330011961 | IPILIMUMAB |